Safety and Efficacy of Vancomycin Plus Beta-lactams

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

December 12, 2018

Primary Completion Date

May 30, 2020

Study Completion Date

May 30, 2020

Conditions
Critical Illness
Interventions
DRUG

vancomycin plus piperacillin/tazobactam

Patients in intensive care unit who received the combination of VAN(vancomycin) and PTZ (piperacillin/tazobactam) for at least 48 hours, had a serum creatinine level measured in the 24-hour of hospital admission.The dosage and frequency of VAN and PTZ was adjusted based on clinical practice and patient characteristics.

DRUG

vancomycin plus other beta-lactams

Patients in intensive care unit who received the combination of VAN (vancomycin) and other beta-lactams (cefoperazone/sulbactam, meropenem, imipenem/siastatin, ceftriaxone, ceftazidime, et al) for at least 48 hours, had a baseline serum creatinine (Scr) concentration value within 24 hours of hospital admission.The dosage and frequency of VAN and other beta-lactams were adjusted based on clinical practice and patient characteristics.

Trial Locations (1)

710061

First Affiliated Hospital of Xian Jiaotong University, Xi'an

All Listed Sponsors
collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT03776409 - Safety and Efficacy of Vancomycin Plus Beta-lactams | Biotech Hunter | Biotech Hunter